What Ozempic & Weight Loss Drugs Really Do to the Body (Video)
In this 22 March 2025 video, host Jonathan Bennion from the Institute of Human Anatomy discusses GLP-1 receptor agonists, a class of medications that includes Ozempic, Wegovy, as well as others that are used for type 2 diabetes and weight loss. We’ll explore how these drugs work, their effectiveness and the potential side effects, as well as considerations for their use in weight loss.
https://youtu.be/SbFf31gHVjY
Table of Contents:
0:00 – Intro: GLP-1 Receptor Agonists: Uses & Overview
1:11 – GLP-1 Receptor Agonists: Names, Including Ozempic, & How They Work
2:13 – The Role of Naturally Produced GLP-1
3:15 – GLP-1 Effects on Pancreas, Insulin & Glucagon
4:04 – How GLP-1 Receptor Agonists Mimic & Enhance GLP-1
5:22 – Semaglutide (Ozempic & Wegovy): Half-Life, Uses & Effectiveness
6:36 – Additional Benefits: Cardiovascular Risk Reduction
7:27 – Potential Side Effects: GI Issues, Fatigue & More
8:26 – Serious Side Effects: Pancreatitis, Gallbladder Issues & Others
9:22 – Muscle Loss: A Serious Consideration
9:45 – Financial Cost: Brand Name vs. Compounding Pharmacies
10:31 – Who Should Consider GLP-1 Receptor Agonists for Weight Loss
11:37 – Importance of Lifestyle Modifications: Diet & Exercise
13:33 – Dietary Considerations & the Role of Strength Training
14:25 – GLP-1 Agonists for Minor Weight Loss? Is It Worth It?
14:44 – The Risk of Weight Regain After Discontinuation
15:40 – Consult Your Healthcare Provider & Final Thoughts
